RYR2 and catecholaminergic polymorphic ventricular tachycardia: Another naturally occurring RyR2 mutation is responsible for catecholaminergic polymorphic ventricular tachycardia (CPVT) in humans, and myocytes from mouse hearts with the same mutation showed increased tendency for store overload induced Ca2+ release [75,76].